137 related articles for article (PubMed ID: 17135055)
1. Pemphigus in the XXI century: new life to an old story.
Grando SA
Autoimmunity; 2006 Nov; 39(7):521-30. PubMed ID: 17135055
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
[TBL] [Abstract][Full Text] [Related]
3. Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis.
Orlov MD; Chernyavsky AI; Arredondo J; Grando SA
Autoimmunity; 2006 Nov; 39(7):557-62. PubMed ID: 17101499
[TBL] [Abstract][Full Text] [Related]
4. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
5. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.
Grando SA; Bystryn JC; Chernyavsky AI; Frusić-Zlotkin M; Gniadecki R; Lotti R; Milner Y; Pittelkow MR; Pincelli C
Exp Dermatol; 2009 Sep; 18(9):764-70. PubMed ID: 19555352
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
7. Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus.
Sharma P; Mao X; Payne AS
J Dermatol Sci; 2007 Oct; 48(1):1-14. PubMed ID: 17574391
[TBL] [Abstract][Full Text] [Related]
8. Significance of autoimmunity to non-desmoglein targets in pemphigus.
Kurzen H; Brenner S
Autoimmunity; 2006 Nov; 39(7):549-56. PubMed ID: 17101498
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
[TBL] [Abstract][Full Text] [Related]
10. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
11. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause.
Cirillo N; Lanza M; Femiano F; Gaeta GM; De Rosa A; Gombos F; Lanza A
J Cell Physiol; 2007 Sep; 212(3):563-7. PubMed ID: 17474087
[TBL] [Abstract][Full Text] [Related]
12. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus: the promises of peptide immunotherapy.
Di Bisceglie MB; Lucchese A; Crincoli V
Immunopharmacol Immunotoxicol; 2009; 31(4):509-15. PubMed ID: 19874216
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic control of epidermal cohesion.
Grando SA
Exp Dermatol; 2006 Apr; 15(4):265-82. PubMed ID: 16512874
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic human monoclonal antibody against desmoglein 3.
Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
[TBL] [Abstract][Full Text] [Related]
16. How does acantholysis occur in pemphigus vulgaris: a critical review.
Lanza A; Cirillo N; Femiano F; Gombos F
J Cutan Pathol; 2006 Jun; 33(6):401-12. PubMed ID: 16776715
[TBL] [Abstract][Full Text] [Related]
17. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
Cirillo N; Gombos F; Lanza A
J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
[TBL] [Abstract][Full Text] [Related]
18. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
20. Searching for experimental models of Pemphigus vulgaris.
Cirillo N; Gombos F; Ruocco V; Lanza A
Arch Dermatol Res; 2007 Apr; 299(1):9-12. PubMed ID: 17377799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
